Document Detail


Mechanical and suboptimal pharmacologic prophylaxis and delayed mobilization but not morbid obesity are associated with venous thromboembolism after total knee arthroplasty: A case-control study.
MedLine Citation:
PMID:  23042665     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: The FDA-approved dose of low-molecular-weight heparin (LMWH) may not provide adequate thromboprophylaxis in morbidly obese patients after total knee arthroplasty (TKA). Suboptimal dosing, delayed initiation, and overreliance on mechanical methods may also limit the effectiveness of thromboprophylaxis. OBJECTIVE: We explored the associations between the type of thromboprophylaxis, obesity, time of mobilization, and undergoing bilateral TKA on development of symptomatic venous thromboembolism (VTE) after TKA. DESIGN/SETTING/PATIENTS: This was a case-control study of patients undergoing TKA in 15 teaching hospitals between October 2008 and March 2010. Cases were screened using the Agency for Healthcare Research and Quality's Patient Safety Indicator 12 and had objectively documented acute VTE within 9 days of surgery; controls were randomly selected from the same hospital. Multivariable logistic regression was used to analyze risk factors for postoperative VTE, adjusted for age and gender. RESULTS: Among 130 cases with and 463 controls without acute VTE, body mass index (BMI) ranged from 17 to 61 (median = 34). Thromboprophylaxis was LMWH in 284 (48%), warfarin in 189 (32%), both in 55 (10%), and mechanical prophylaxis alone in 120 (20%). Overall, 77% ambulated on day 1 or 2 after surgery. Factors significantly associated with VTE were bilateral simultaneous TKA (odds ratio [OR] = 4.2; 95% confidence interval [CI]: 1.9-9.1), receipt of FDA-approved pharmacological prophylaxis (OR = 0.5; 95% CI: 0.3-0.8), and ambulation by postoperative day 2 (OR = 0.3; 95% CI: 0.1-0.9). Obesity was neither a significant confounder nor a modifier of these effects. CONCLUSIONS: Severe obesity was not a significant independent predictor for VTE and did not modify the beneficial effect of FDA-approved pharmacological thromboprophylaxis. Bilateral TKA and failure to ambulate by the second day after surgery were significant risk factors. Journal of Hospital Medicine 2012; © 2012 Society of Hospital Medicine.
Authors:
Banafsheh Sadeghi; Patrick S Romano; Gregory Maynard; Amy L Strater; Laurie Hensley; Julie Cerese; Richard H White
Related Documents :
1509235 - Serum carcinoembryonic antigen: a prognostic marker in hiv-related pneumocystis carinii...
19717025 - Lies, damned lies, and statistics: a neurosurgical perspective on the international ran...
17339145 - Outcome and prognostic factors of decompressive hemicraniectomy in malignant middle cer...
8619185 - Does the choice of material influence early morbidity in patients undergoing carotid pa...
20508305 - Prospective study of prostate cancer's detection rate at our hospital in northeast mexi...
11952185 - Cognitive-behavioral therapy for bulimia nervosa: time course and mechanisms of change.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-5
Journal Detail:
Title:  Journal of hospital medicine : an official publication of the Society of Hospital Medicine     Volume:  -     ISSN:  1553-5606     ISO Abbreviation:  J Hosp Med     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-8     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101271025     Medline TA:  J Hosp Med     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Society of Hospital Medicine.
Affiliation:
School of Medicine, Department of Internal Medicine, Division of General Medicine. bsadeghi@ucdavis.edu.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Diurnal cortisol rhythms and child growth: Exploring the life history consequences of HPA activation...
Next Document:  Lead Optimization of Thiazolo[5,4-c]piperidines: 3-Cyclobutoxy Linker as a Key Spacer for H(3) R Inv...